Key facts
- This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Mar 2025, 17:59.
John E. Kao - 13 Mar 2025 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ALHC
- Reported as of
- 13 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Mar 2025, 17:59:25 UTC
- Prior SEC filing
- 13 Mar 2025
- Next SEC filing
- 19 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 17 Mar 2025.
Change
- Previous filing in this sequence was filed on 13 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +338,710
- Change %
- +7.2%
- Price
- $0.000000
- Shares after
- 5,019,252
- Date
- 13 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
ALHC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,093,100
- Date
- 13 Mar 2025
- Ownership
- See Footnote
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents (i) 274,194 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 64,516 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors.
Footnote F2
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.